Preferential recognition of a microbial metabolite by human Vγ2Vδ2 T cells

International Immunology

Volumn 19, Issue 5, 2007, Pages 657-673

  Puan, Kia Joo ^a   Jin, Chenggang ^a   Wang, Hong ^a   Sarikonda, Ghanashyam ^a   Raker, Amy M ^a   Lee, Hoi K ^a   Samuelson, Megan I ^a   Märker Hermann, Elisabeth ^b   Pasa Tolic, Ljiljana ^c   Nieves, Edward ^d   Giner, José Luis ^e   Kuzuyama, Tomohisa ^f   Morita, Craig T ^a  

^a UNIVERSITY OF IOWA   (United States)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

T cells; 2 C methyl D erythritol 4 phosphate pathway; Microbial immunity; Prenyl pyrophosphate antigens

Indexed keywords

2 C METHYL DEXTRO ERYTHRITOL 4 PHOSPHATE; 3 FORMYL 1 BUTYLPYROPHOSPHATE; 4 HYDROXY 3 METHYLBUT 2 ENYLPYROPHOSPHATE; BACTERIAL ANTIGEN; ISOPENTENYL DIPHOSPHATE; ISOPRENOID; PYROPHOSPHORIC ACID DERIVATIVE; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; IN VIVO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; YERSINIA ENTEROCOLITICA;

ANIMALS; DIPHOSPHATES; HEMITERPENES; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MODELS, ANIMAL; MOLECULAR STRUCTURE; MYCOBACTERIUM SMEGMATIS; ORGANOPHOSPHORUS COMPOUNDS; POLYISOPRENYL PHOSPHATES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 34447520312     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm031     Document Type: Article

References (116)

1. Tanaka, Y., Sano, S., Nieves, E. et al. 1994. Nonpeptide ligands for human γδ T cells. Proc. Natl Acad. Sci. USA 91:8175.
2. Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B. and Bloom, B. R. 1995. Natural and synthetic non-peptide antigens recognized by human δγ T cells. Nature 375:155.
3. Balbi, B., Moller, D. R., Kirby, M., Holroyd, K. J. and Crystal, R. G. 1990. Increased numbers of T lymphocytes with δγ-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis. J. Clin. Invest 85:1353.
4. + antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am. Rev. Respir. Dis. 148:1685.
5. Barnes, P. F., Grisso, C. L., Abrams, J. S., Band, H., Rea, T. H. and Modlin, R. L. 1992. γδ T lymphocytes in human tuberculosis. J. Infect. Dis. 165:506.
6. Modlin, R. L., Pirmez, C., Hofman, F. M. et al. 1989. Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions. Nature 339:544.
7. Hara, T., Mizuno, Y., Takaki, K. et al. 1992. Predominant activation and expansion of Vγ9-bearing γδ T cells in vivo as well as in vitro in Salmonella infection. J. Clin. Invest. 90:204.
8. Bertotto, A., Gerli, R., Spinozzi, F. et al. 1993. Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection. Eur. J. Immunol. 23:1177.
9. Poquet, Y., Kroca, M., Halary, F. et al. 1998. Expansion of Vγ9Vδ2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect. Immun. 66:2107.
10. Sumida, T., Maeda, T., Takahashi, H. et al. 1992. Predominant expansion of Vγ9/Vδ2 Tcells in a tularemia patient. Infect. Immun. 60:2554.
11. Kroca, M., Tärnvik, A. and Sjöstedt, A. 2000. The proportion of circulating γδ T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin. Exp. Immunol. 120:280.
12. Caldwell, C. W., Everett, E. D., McDonald, G., Yesus, Y. W. and Roland, W. E. 1995. Lymphocytosis of γ/δ T cells in human ehrlichiosis. Am. J. Clin. Pathol. 103:761.
13. Ho. M., Webster, H. K., Tongtawe, P., Pattanapanyasat, K. and Weidanz, W. P. 1990. Increased γδ T cells in acute Plasmodium falciparum malaria. Immunol. Lett. 25:139.
14. Perera, M. K., Carter, R., Goonewardene, R. and Mendis, K. N. 1994. Transient increases in circulating ©/™ T cells during Plasmodium vivax malarial paroxysms. J. Exp. Med. 179:311.
15. Scalise, F., Gerli, R., Castellucci, G. et al. 1992. Lymphocytes bearing the γδ T-cell receptor in acute toxoplasmosis. Immunology 76:668.
16. Wang, L., Kamath, A., Das, H., Li, L. and Bukowski, J. F. 2001. Antibacterial effect of human Vγ2Vδ2 T cells in vivo. J. Clin. Invest. 108:1349.
17. + T cells during mycobacterial infections. Science 295:2255.
18. Eberl, M., Hintz, M., Reichenberg, A., Kollas, A.-K., Wiesner, J. and Jomaa, H. 2003. Microbial isoprenoid biosynthesis and human γδ T cell activation. FEBS Lett. 544:4.
19. Rohmer, M. 2003. Mevalonate-independent methylerythritol phosphate pathway for isoprenoid biosynthesis. Elucidation and distribution. Pure Appl. Chem. 75:375.
20. Eisenreich, W., Bacher, A., Arigoni, D. and Rohdich, F. 2004. Biosynthesis of isoprenoids via the non-mevalonate pathway. Cell. Mol. Life Sci. 61:1401.
21. Hecht, S., Eisenreich, W., Adam, P. et al. 2001. Studies on the nonmevalonate pathway to terpenes: The role of the GcpE (IspG) protein. Proc. Natl. Acad. Sci. USA 98:14837.
22. Rohdich, F., Hecht, S., Gartner, K. et al. 2002. Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein. Proc. Natl Acad. Sci. USA 99:1158.
23. Hintz, M., Reichenberg, A., Altincicek, B. et al. 2001. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human γδ T cells in Escherichia coli. FEBS Lett. 509:317.
24. Altincicek, B., Moll, J., Campos, N. et al. 2001. Human γδ T cells are activated by intermediates of the 2-C mmethyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis. J. Immunol. 166:3655.
25. Eberl, M., Altincicek, B., Kollas, A.-K. et al. 2002. Accumulation of a potent γδ T-cell stimulator after deletion of the lytB gene in Escherichia coli. Immunology 106:200.
26. Eberl, M., Hintz, M., Jamba, Z., Beck, E., Jomaa, H. and Christiansen, G. 2004. Mycoplasma penetrans is capable of activating Vγ9/Vδ2 T cells while other human pathogenic mycoplasmas fail to do so. Infect. Immun. 72:4881.
27. Begley, M., Gahan, C. G., Kollas, A.-K. et al. 2004. The interplay between classical and alternative isoprenoid biosynthesis controls γδ T cell bioactivity of Listeria monocytogenes. FEBS Lett. 561:99.
28. Constant, P., Davodeau, F., Peyrat, M.-A. et al. 1994. Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264:267.
29. Belmant, C., Espinosa, E., Poupot, R. et al. 1999. 3-formyl-1-butyl pyrophosphate a novel mycobacterial metabolite-activating human γδ T cells. J. Biol. Chem. 274:32079.
30. Poquet, Y., Constant, P., Halary, F. et al. 1996. A novel nucleotide-containing antigen for human blood γδ T lymphocytes. Eur. J. Immunol. 26:2344.
31. Feurle, J., Espinosa, E., Eckstein, S. et al. 2002. Escherichia coli produces phosphoantigens activating human γδ T cells. J. Biol. Chem. 277:148.
32. Pont, F., Luciani, B., Belmant, C. and Fournié, J. J. 2001. Characterization of phosphoantigens by high-performance an-ion-exchange chromatography-electrospray ionization ion trap mass spectrometry and nanoelectrospray ionization ion trap mass spectrometry. Anal. Chem. 73:3562.
33. Munk, M. E., Gatrill, A. J. and Kaufmann, S. H. E. 1990. Target cell lysis and IL-2 secretion by γ/δ T lymphocytes after activation with bacteria. J. Immunol. 145:2434.
34. + γ/δ T cells by group A, B and C but not group D or F streptococci. Clin. Exp. Immunol. 89:301.
35. Zhang, Y., Song, Y., Yin, F. et al. 2006. Structural studies of Vγ2Vδ2 T cell phosphoantigens. Chem. Biol. 13:985.
36. 13C]-labeled form. Tetrahedron Lett. 43:5457.
37. Morita, C. T., Verma, S., Aparicio, P., Martinez-A, C., Spits, H. and Brenner, M. B. 1991. Functionally distinct subsets of human γ/δ T cells. Eur. J. Immunol. 21:2999.
38. Morita, C. T., Parker, C. M., Brenner, M. B. and Band, H. 1994. T cell receptor usage and functional capabilities of human γδ T cells at birth. J. Immunol. 153:3979.
39. Takahashi, S., Kuzuyama, T., Watanabe, H. and Seto, H. 1998. A 1-deoxy-D-xylulose 5-phosphate reductoisomerase catalyzing the formation of 2-C-methyl-D-erythritol 4-phosphate in an alternative nonmevalonate pathway for terpenoid biosynthesis. Proc. Natl Acad. Sci. USA 95:9879.
40. Takagi, M., Kuzuyama, T., Kaneda, K., Watanabe, H., Dairi, T. and Seto, H. 2000. Studies on the nonmevalonate pathway: Formation of 2-C methyl-D-erythritol 2,4-cyclodiphosphate from 2-phospho-4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol. Tetrahedron Lett. 41:3395.
41. Kuzuyama, T., Takagi, M., Kaneda, K., Watanabe, H., Dairi, T. and Seto, H. 2000. Studies on the nonmevalonate pathway: Conversion of 4-(cytidine 5′-diphospho)-2-C-methyl-D-erythritol to its 2-phospho derivative by 4-(cytidine 5′-diphospho -2-C-methyl-D-erythritol kinase. Tetrahedron Lett. 41:2925.
42. Kuzuyama, T., Takagi, M., Kaneda, K., Dairi, T. and Seto, H. 2000. Formation of 4-(cytidine 5′-diphospho -2-C-methyl-D-erythritol from 2-C-methyl-D-erythritol 4-phosphate by 2-C methyl-D-erythritol 4-phosphate cytidytyltransferase, a new enzyme in the nonmevalonate pathway. Tetrahedron Lett. 41:703.
43. Kaneda, K., Kuzuyama, T., Takagi, M., Hayakawa, Y. and Seto, H. 2001. An unusual isopentenyl diphosphate isomerase found in the mevalonate pathway gene cluster from Streptomyces sp. strain CL190. Proc. Natl Acad. Sci. USA 98:932.
44. Puan, K.-J., Wang, H., Dairi, T., Kuzuyama, T. and Morita, C. T. 2005. fldA is an essential gene required in the 2-C methyl-D-erythritol 4-phosphate pathway for isoprenoid biosynthesis. FEBS Lett. 579:3802.
45. Kuzuyama, T., Takahashi, S. and Seto, H. 1999. Construction and characterization of Escherichia coli disruptants defective in the yaeM gene. Biosci. Biotechnol. Biochem. 63:776.
46. Hacker, G., Kromer, S., Heeg, K., Ivanyi, J., Wagner, H. and Pfeffer, K. 1992. Opportunist mycobacteria express ligands that stimulate production of human Vγ9Vδ2 T lymphocytes. Infect. Immun. 60:2753.
47. Pfeffer, K., Schoel, B., Gulle, H., Kaufmann, S. H. E. and Wagner, H. 1990. Primary responses of human T cells to mycobacteria: A frequent set of γ/δ T cells are stimulated by protease-resistant ligands. Eur. J. Immunol. 20:1175.
48. + human γδ T cells. J. Immunol. 148:575.
49. Morita, C. T., Beckman, E. M., Bukowski, J. F. et al. 1995. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 3:495.
50. Delfau, M.-H., Hance, A. J., Lecossier, D., Vilmer, E. and Grandchamp, B. 1992. Restricted diversity of Vγ9-JP rearrangements in unstimulated human γ/δ T lymphocytes. Eur. J. Immunol. 22:2437.
51. Panchamoorthy, G., McLean, J., Modlin, R. L. et al. 1991. A predominance of the T cell receptor Vγ9Vδ2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J. Immunol. 147:3360.
52. Fisch, P., Malkovsky, M., Kovats, S. et al. 1990. Recognition by human Vγ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250:1269.
53. Montesano, C., Gioia, C., Martini, F. et al. 2001. Antiviral activity and anergy of γδ T lymphocytes in cord blood and immuno-compromised host. J. Biol. Regul. Homeost. Agents 15:257.
54. Wang, L., Das, H., Kamath, A., Li, L. and Bukowski, J. F. 2002. Human Vγ2Vδ2 T cells augment migration-inhibitory factor secretion and counteract the inhibitory effect of glucocorticoids on IL- 1β and TNF-α production. J. Immunol. 168:4889.
55. Jomaa, H., Feurle, J., Luhs, K. et al. 1999. Vγ9/Vδ2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis. FEMS Immunol Med Microbiol 25:371.
56. Reichenberg, A., Hintz, M., Kletschek, Y. et al. 2003. Replacing the pyrophosphate group of HMB-PP by a diphosphonate function abrogates its potential to activate human γδ T cells but does not lead to competitive antagonism. Bioorg. Med. Chem. Lett. 13:1257.
57. Simondsen, R. P. and Tollin, G. 1980. Structure-function relations in flavodoxin. Mol. Cell. Biochem. 33:13.
58. Osborne, C., Chen, L. M. and Matthews, R. G. 1991. Isolation, cloning, mapping, and nucleotide sequencing of the gene encoding flavodoxin in Escherichia coli. J. Bacteriol. 173:1729.
59. Seemann, M., Bui, B. T., Wolff, M. et al. 2002. Isoprenoid biosynthesis through the methylerythritol phosphate pathway: The (E -4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) is a [4Fe-4S] protein. Angew Chem. Int. Ed. Engl. 41:4337.
60. Gräwert, T., Kaiser, J., Zepeck, F. et al. 2004. IspH protein of Escherichia coli: Studies on iron-sulfur cluster implementation and catalysis. J. Am. Chem. Soc. 126:12847.
61. Bukowski, J. F., Morita, C. T., Tanaka, Y., Bloom, B. R., Brenner, M. B. and Band, H. 1995. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:998.
62. Tamura, N., Holroyd, K. J., Banks, T., Kirby, M., Okayama, H. and Crystal, R. G. 1990. Diversity in junctional sequences associated with the common human Vγ9 and Vδ2 gene segments in normal blood and lung compared with the limited diversity in a granulomatous disease. J. Exp. Med. 172:169.
63. Evans, P. S., Enders, P. J., Yin, C., Ruckwardt, T. J., Malkovsky, M. and Pauza, C. D. 2001. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vγ2-Jγ1.2/Vδ2 T-cell receptors. Immunology 104:19.
64. Davodeau, F., Peyrat, M. A., Hallet, M. M., Houde, I., Vie, H. and Bonneville, M. 1993. Peripheral selection of antigen receptor junctional features in a major human γδ subset. Eur. J. Immunol. 23:804.
65. Blattman, J. N., Antia, R., Sourdive, D. J. et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657.
66. + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J. Exp. Med. 171:667.
67. Davodeau, F., Peyrat, M.-A., Hallet, M.-M. et al. 1993. Close correlation between Daudi and mycobacterial antigen recognition by human γδ T cells and expression of V9JPC1γ/V2DJCδ-encoded T cell receptors. J. Immunol. 151:1214.
68. De Libero, G., Casorati, G., Giachino, C. et al. 1991. Selection by two powerful antigens may account for the presence of the major population of human peripheral γ/δ T cells. J. Exp. Med. 173:1311.
69. Parker, C. M., Groh, V., Band, H. et al. 1990. Evidence for extrathymic changes in the T cell receptor γ/δ repertoire. J. Exp. Med. 171:1597.
70. Murphy, W. J., Conlon, K. C., Sayers, T. J. et al. 1993. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J. Immunol. 150:3634.
71. Wong, P. and Pamer, E. G. 2001. Antigen-independent CD8 T cell proliferation. J. Immunol. 166:5864.
72. Mercado, R., Vijh, S., Allen, S. E., Kerksiek, K., Pilip, I. M. and Pamer, E. G. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165:6833.
73. Casetti, R., Perretta, G., Taglioni, A. et al. 2005. Drug-induced expansion and differentiation of Vγ9Vδ82 T cells in vivo: The role of exogenous IL-2. J. Immunol. 175:1593.
74. Sicard, H., Ingoure, S., Luciani, B. et al. 2005. In vivo immunomanipulation of Vγ9Vδ2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 175:5471.
75. Wilhelm, M., Kunzmann, V, Eckstein, S. et al. 2003. γδ T cells for immune therapy of patients with lymphoid malignancies. Blood 102:200.
76. De Rosa, S. C., Andrus, J. P., Perfetto, S. P., Mantovani, J. J., Herzenberg, L. A. and Roederer, M. 2004. Ontogeny of γδ T cells in humans. J. Immunol. 172:1637.
77. Lopes-Carvalho, T and Kearney, J. F. 2004. Development and selection of marginal zone B cells. Immunol. Rev. 197:192.
78. Pillai, S., Cariappa, A. and Moran, S. T. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161.
79. Kearney, J. F. 2005. Innate-like B cells. Springer Semin. Immunopathol. 26:377.
80. Takeda, K., Kaisho, T and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335.
81. Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
82. 3Cys. Infect. Immun. 74:4505.
83. Rothenfusser, S., Hornung, V, Krug, A. et al. 2001. Distinct CpG oligonucleotide sequences activate human γδ T cells via interferon-α/ -β. Eur J. Immunol. 31:3525.
84. Kunzmann, V, Kretzschmar, E., Herrmann, T. and Wilhelm, M. 2004. Polyinosinic-polycytidylic acid-mediated stimulation of human γδ T cells via CD11c dendritic cell-derived type I interferons. Immunology 112:369.
85. Morita, C. T, Mariuzza, R. A. and Brenner, M. B. 2000. Antigen recognition by human γδ T cells: Pattern recognition by the adaptive immune system. Springer Semin. Immunopathol. 22:191.
86. Morita, C. T., Jin, C., Sarikonda, G. and Wang, H. 2007. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: Discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215:59.
87. Havlir, D. V., Ellner, J. J., Chervenak, K. A. and Boom, W. H. 1991. Selective expansion of human γδ T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 87:729.
88. Worku, S. and Hoft, D. F. 2003. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect. Immun. 71:1763.
89. Boom, W. H., Chervenak, K. A., Mincek, M. A. and Ellner, J. J. 1992. Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live Mycobacterium tuberculosis. Infect. Immun. 60:3480.
90. Spada, F. M., Grant, E. P., Peters, P. J. et al. 2000. Self recognition of CD1 by γδ T cells: Implications for innate immunity. J. Exp. Med. 191:937.
91. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J. Immunol. 154:1786.
92. Ottones, F, Dornand, J., Naroeni, A., Liautard, J. P. and Favero, J. 2000. Vγ9Vδ2 T cells impair intracellular multiplication of Brucella suis in autologous monocytes through soluble factor release and contact-dependent cytotoxic effect. J. Immunol. 165:7133.
93. Dieli, F., Troye-Blomberg, M., Ivanyi, J. et al. 2000. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 30:1512.
94. Elloso, M. M., van der Heyde, H. C., vande Waa, J. A., Manning, D. D. and Weidanz, W. P. 1994. Inhibition of Plasmodium falciparum in vitro by human γδ T cells. J. Immunol. 153:1187.
95. Dieli, F., Troye-Blomberg, M., Ivanyi, J. et al. 2001. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vγ9/Vδ2 T lymphocytes. J. Infect Dis. 184:1082.
96. Oliaro, J., Dudal, S., Liautard, J., Andrault, J. B., Liautard, J. P. and Lafont, V 2005. Vγ9Vδ2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella. J. Leukoc. Biol. 77:652.
97. Farouk, S. E., Mincheva-Nilsson, L., Krensky, A. M., Dieli, F. and Troye-Blomberg, M. 2004. γδ T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur. J. Immunol. 34:2248.
98. Jin, C. and Morita, C. T. 2006. Chemokine biology of NK cells and γδ T cells. In Mosser, B., Letts, G. L. and Neote, K., eds, Chemokine Biology - Basic Research and Clinical Applications: Vol. 1: Immunobiology of Chemokines. Birkhäuser, Basel.
99. García, V. E., Sieling, P. A., Gong, J.-H. et al. 1997. Single cell cytokine analysis of γδ T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159:1328.
100. Poccia, F., Battistini, L., Cipriani, B. et al. 1999. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J. Infect. Dis. 180:858.
101. Cipriani, B., Borsellino, G., Poccia, F. et al. 2000. Activation of C-C β-chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood 95:39.
102. Tikhonov, I., Deetz, C. O., Paca, R. et al. 2006. Human Vγ2Vδ2 T cells contain cytoplasmic RANTES. Int. Immunol. 18:1243.
103. Dudal, S., Turriere, C., Bessoles, S. et al. 2006. Release of LL-37 by activated human Vγ9Vδ2 T cells: A microbicidal weapon against Brucella suis. J. Immunol. 177:5533.
104. Workalemahu, G., Foerster, M., Kroegel, C. and Braun, R. K. 2003. Human γδ-T lymphocytes express and synthesize connective tissue growth factor: Effect of IL-15 and TGF-β1 and comparison with αβ-T lymphocytes. J. Immunol. 170:153.
105. Workalemahu, G., Foerster, M. and Kroegel, C. 2004. Expression and synthesis of fibroblast growth factor-9 in human γδ T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-β1/IL-15. J. Leukoc. Biol. 75:657.
106. Workalemahu, G., Foerster, M. and Kroegel, C. 2006. Expression of metalloproteinase-7 (matrilysin) in human blood and bronchoalveolar gamma/delta T-lymphocytes. Selective upregulation by the soluble non-peptidic mycobacterial phosphoantigen (isopentenyl pyrophosphate). J. Cell Physiol. 207:67.
107. Ziegler, H. K. 2004. The role of γ/δ T cells in immunity to infection and regulation of inflammation. Immunol Res. 29:293.
108. Pennington, D. J., Vermijlen, D., Wise, E. L., Clarke, S. L., Tigelaar, R. E. and Hayday, A. C. 2005. The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Adv. Immunol. 87:27.
109. Gober, H. J., Kistowska, M., Angman, L., Jeno, P., Mori, L. and De Libero, G. 2003. Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197:163.
110. Thompson, K. and Rogers, M. J. 2004. Statins prevent bisphosphonate-induced γδ-T-cell proliferation and activation in vitro. J. Bone Miner. Res. 19:278.
111. Thompson, K., Rojas-Navea, J. and Rogers, M. J. 2006. Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathway. Blood 107:651.
112. + γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J. Urol. 173:1552.
113. Zheng, B. J., Chan, K. W., Im, S. et al. 2001. Anti-tumor effects of human peripheral γδ T cells in a mouse tumor model. Int. J. Cancer 92:421.
114. Choudhary, A., Davodeau, F., Moreau, A., Peyrat, M.-A., Bonneville, M. and Jotereau, F. 1995. Selective lysis of autologous tumor cells by recurrent γδ tumor-infiltrating lymphocytes from renal carcinoma. J. Immunol. 154:3932.
115. Viey, E., Fromont, G., Escudier, B. et al. 2005. Phosphostim-activated γδ T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174:1338.
116. Corvaisier, M., Moreau-Aubry, A., Diez, E. et al. 2005. Vγ2Vδ2 T cell response to colon carcinoma cells. J. Immunol. 175:5481.